Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism()

Tight control of glucose excursions has been a long-standing goal of treatment for patients with type 2 diabetes mellitus in order to ameliorate the morbidity and mortality associated with hyperglycemia. Fibroblast growth factor (FGF) 19 is a hormone-like enterokine released postprandially that emer...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcelin, Geneviève, Jo, Young-Hwan, Li, Xiaosong, Schwartz, Gary J., Zhang, Ying, Dun, Nae J., Lyu, Rong-Ming, Blouet, Clémence, Chang, Jaw K., Chua, Streamson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929918/
https://www.ncbi.nlm.nih.gov/pubmed/24567901
http://dx.doi.org/10.1016/j.molmet.2013.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929918/
https://www.ncbi.nlm.nih.gov/pubmed/24567901
http://dx.doi.org/10.1016/j.molmet.2013.10.002

Ejemplares similares